Herpes Marker Testing Market: Overview
Owing to the high prevalence of herpes simplex virus of both types, HSV- 1 and HSV- 2, the demand for herpes marker testing is receiving a stimulus. According to estimates of Centers for Disease Control and Prevention, each year in the U.S., 776,000 people get new genital herpes infections. Countrywide, 11.9% of the population aged between 14 and 49 years have HSV-2 infection, with African- American female population mainly affected.
Furthermore, according to data presented by the Public Health Agency of Canada, prevalence of HSV-1 infection is higher than HSV-2 in most parts of the world. The data also shows seroprevalence in adults is above 70% in developed countries, and almost 100% in developing and underdeveloped countries.
The study on the herpes marker testing market provides a pinpoint analysis of demand dynamics, growth indices, and vendor landscape of the said market for the 2015 – 2023 forecast period.
Herpes Marker Testing Market: Key Trends
Growth of herpes marker testing market stems from ubiquity of herpes virus and asymptomatic nature of the infection. More than 80% herpes infections are asymptomatic, because of which physicians depend on diagnostic tests for correct diagnosis and treatment. Some symptoms of herpes infection are blistering sores, swollen lymph nodes, pain during urination, and fever.
High risk of contraction of herpes virus by close contact with an infected individual is pushing the growth of herpes marker testing market. The virus is transmitted through body fluids such as blood, saliva, and semen. Some studies suggest herpes virus is transmitted through breast milk.
Less number of diagnostic tests available for herpes simplex virus (HSV) is another factor behind growth of herpes marker testing market. Currently, there are four tests available for HSV biomarker testing, namely, antigen tests, cell culture tests, polymerase chain reaction, and antibody tests. Of all, polymerase chain reaction tests are most accurate for diagnosis of HSV. Whilst, cell culture tests have chance of false negative results, and are time consuming too. This arouses need for new diagnostic tests for HSV biomarker testing.
Herpes Marker Testing Market: Geographical Analysis
North America, among all, is the forefront in terms of clinical trials for herpes marker testing. Medical insurance coverage for HSV testing and presence of state-of-the-art testing facilities are other factors that make the region prominent. High awareness among individuals to seek medical testing for symptomatic HSV also accounts for substantial revenue of the region in the overall herpes marker testing market. Furthermore, higher seroprevalence of HSV and large number of HIV patients are some other factors that pushes growth of North America herpes marker testing market.
On the other hand, limited knowledge of HSV among individuals of developing countries is a factor for small revenue of Asia Pacific herpes marker testing market. Due to the economic conditions and limited medical facilities, cost-effective diagnosis tests are in high demand in developing countries of Asia Pacific.
Herpes Marker Testing Market: Competitive Landscape
Keen players in the herpes marker testing market are making strides for diagnostic tests for HSV1- and HSV- 2. R&D and clinical trials is the focus of top players in the herpes market testing market. In 2014, Simplexa HSV 1 and HSV 2 direct molecular test by Quest Diagnostics are the first ones to receive U.S. FDA’s approval. The Simplexa test is the first one approved by U.S. FDA that enables qualitative differentiation and detection of HSV-1 and HSV- 2 in cerebrospinal fluid.
Some other top players in the herpes marker testing market are Trinity Biotech, Biohelix, Focus Diagnostics, DiaSorin, Roche, Thermo Fisher Scientific, and Enzo Life Sciences.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.